Nutritional supplement to change body composition in women during perimenopause
Official title: A Pilot Study Investigating the Effects of a Nutritional Supplement on Physiological and Metabolic Markers in 38-55-year-old Females
Run by University of Southampton · NCT07615777 · Data updated 2026-11-12
A 12-week test of a supplement containing myo-inositol, berberine, cinnamon, and chromium to see if it changes body fat and other metabolic markers in women aged 38-55 compared with a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 38 Years to 55 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | University of Southampton Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Southampton, Hampshire) |
| Status | Recruiting |
| Started | July 9, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07615777 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 38-55 who have irregular menstrual cycles or menopausal symptoms and are willing to avoid other supplements during the study.
✕Probably not a fit
Individuals with diabetes, very low BMI, recent cancer, or other listed exclusions may not experience benefit and could be at higher risk if enrolled.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests whether a 12-week nutritional supplement can alter body composition and related metabolic markers in perimenopausal women aged 38-55. Participants will be randomized to receive either the supplement or a placebo, with outcomes including body mass index, body fat composition, plasma and urine metabolites, menopausal symptoms, and physical performance measures like grip strength. The trial uses standard randomized, placebo-controlled design to compare changes between groups over the 12 weeks. Eligible participants are women 38-55 with irregular cycles or menopausal symptoms, not taking other supplements, and without certain exclusion conditions. Primary aim is to determine if the supplement produces meaningful changes in body composition relative to placebo.
Why it matters
Potential benefit: If successful, participants may experience favorable changes in body composition and related metabolic and symptom measures.
How similar studies have gone: Similar multi-ingredient nutritional approaches have shown signals in metabolic and body composition outcomes in related populations, but results are variable and often not definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Assigned sex at birth is female * Aged 38-55 years * Experiencing irregular menstrual cycles but not amenorrheic for more than 12 months or have at least one of the following recent symptoms (i.e., from 38 years onwards): (1) hot flushes, (2) sleep disturbances, (3) mood swings, (4) concentration difficulties, (5) bloating or (6) weight gain. * Willing to avoid taking other food supplements during the study period * Able to provide written informed consent Exclusion Criteria: * Diabetes * BMI \<18.5 kg/m2 * Pregnant or trying to get pregnant * No active cancer or cancer within last 5 years * Total Hysterectomy * Known allergies to cinnamon extract, chromium, berberine, myo-inositol * Currently taking part in research, or have done within the last 3 months * Diagnosed autoimmune diseases * Diagnosed hypoglycemia
Where it's running
-
NIHR Southampton Clinical Research Facility
Southampton, Hampshire, United Kingdom Recruiting
Study contacts
- Principal investigator: Colleen S Deane, PhD — University of Southampton
- Study coordinator: Colleen S Deane, PhD
- Email: c.s.deane@soton.ac.uk
- Phone: +44 2381208664
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Probiotic Intake to See If It Helps Perimenopausal Women Think and Feel Better
We’re testing whether a multi-strain probiotic can improve emotional processing and cognitive function in perimenopausal women who have mood or cognitive concerns.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
-
Six-month high-fiber, high-polyphenol diet to lower brain inflammation in perimenopausal women with overweight or obesity
This will try a 6-month high-fiber, high-polyphenol (polybiotic) diet to see if it lowers brain inflammation in perimenopausal women with overweight or obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.